Your doctor will stage, or determine how far along your cancer is, as part of your diagnosis. Staging the disease helps your doctor understand where your disease is in its progression and may help him or her determine the best course of treatment for your individual case. Staging can be a...
The biology of lung cancer results in symptoms after the disease is significantly advanced — and metastatic — and, as a consequence, 90% of patients die of their disease within 1–2 years.doi:10.1016/S1359-6349(10)70823-5T. Jacks
Intrinsic electrical activity drives small-cell lung cancer progression Electrical excitability in neuroendocrine SCLC cells promotes tumour progression through action potential firing, increasing ATP demand and oxidative phosphorylation dependency, whereas non-neuroendocrine cells provide metabolic support, driving ...
there is an urgent need for effective strategies to cure or manage lung cancer, particularly late-stage cancers [11]. The prognosis of NSCLC is challenging due to the unavailability of a platform for early-stage diagnosis and the late appearance of symptoms in disease...
For individuals with lung cancer who exhibit pre-existing symptoms, the onset or worsening of respiratory distress, chest pain, hemoptysis, anxiety, decreased oxygen saturation, and other clinical signs should prompt consideration of both tumor progression and the presence of SPE. Misdiagnosis or under...
D. Anderson Symptom Inventory (MDASI) developed specifically for patients with lung cancer (MDASI-LC). The MDASI measures 13 common “core” symptoms of cancer and its treatment. The MDASI-LC includes the 13 core MDASI symptom items and three lung cancer–specific ...
The game-changing CROWN study has unveiled an unparalleled breakthrough - Lorlatinib (3rd generation inhibitor) has not yet reached its median progression-free survival (PFS)%u2026pic.twitter.com/KhmW9xgT3B — Together4Cancer (@T4Cancer)June 3, 2024 ...
Significantly high-expressed circFLNA has been found in various cancer cell lines, but not in lung cancer. Therefore, this study aimed to explore the role of circFLNA in the progression of lung cancer. The target gene of circFLNA was determined by bioinf
Ponsegromab Eases Cancer Cachexia Symptoms, Targets GDF-15 ByRoman Fabbricatore January 21st 2025 FDA Grants Priority Review to Sunvozertinib for NSCLC With EGFR Exon 20 Insertion Mutations ByAshling Wahner January 11th 2025 Amivantamab/Lazertinib Improves Survival in EGFR+ Advanced Lung Cancer ...
PROBLEM IDENTIFICATION: This scoping review aimed to explore symptom clusters (SCs) in patients with lung cancer and how included symptoms and symptom dimensions are measured. LITERATURE SEARCH: PubMed, CINAHL, Scopus, and Cochrane Library were searched for studies published until December 31, 2021....